Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal surface and epithelial adhesion sites constitute a critical biological interface that serves as the primary boundary between the host and the external environment [1]. This target is not a single molecule but a multi-component system consisting of the mucus layer, primarily composed of Mucin-2 (MUC2), the glycocalyx, and the apical membrane of intestinal epithelial cells [2]. Its fundamental biological function is to facilitate the selective absorption of nutrients and water while providing a robust physical and chemical barrier against pathogens and toxins [1]. In conditions such as inflammatory bowel disease (IBD), celiac disease, and various enteric infections, the integrity of these adhesion sites is compromised, leading to increased intestinal permeability and chronic inflammation [3]. Pharmacological strategies targeting this interface include the use of mucoadhesive polymers like chitosan to prolong drug residence time and agents like sucralfate that form a protective coating over damaged mucosa [4]. Additionally, anti-adhesion therapies aim to block the specific receptors used by bacteria and viruses to attach to the epithelium, thereby preventing infection at the source [5]. Probiotics also interact with these sites by competitively occupying adhesion niches, thereby excluding pathogenic species [2]. Understanding the molecular topography of these sites is essential for the development of oral vaccines and targeted delivery of biologics [4]. Citations: [1] Turner JR. Nat Rev Immunol. 2009;9(11):799-809. [2] Johansson ME, et al. PNAS. 2011;108 Suppl 1:4659-65. [3] Khutoryanskiy VV. Macromol Biosci. 2011;11(6):748-64. [4] Pullan RD, et al. Gut. 1994;35(3):353-9. [5] Ofek I, et al. FEMS Immunol Med Microbiol. 2003;38(3):181-91.
Mucoadhesion to increase residence time, physical barrier formation to protect the epithelium, and competitive inhibition of pathogen attachment to epithelial receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal surface and epithelial adhesion sites.